Jarrett Disbrow
Founder at AYTU BIOPHARMA, INC.
Net worth: 36 343 $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John Donofrio | M | 56 |
Vyrix Pharmaceuticals, Inc.
 Vyrix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vyrix Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It maximizes the clinical and commercial potential of its late-stage sexual dysfunction products. The company is currently focused on advancing the development of Zertane™ for Premature Ejaculation (PE) in the US and around the world. Vyrix Pharmaceuticals was founded on November 18, 2013 and is headquartered in Greenwood Village, CO. | 10 years |
| Joshua Disbrow | M | 49 | 9 years | |
| Mark Oki | M | 55 | 2 years | |
| Vivian Liu | F | 62 | 2 years | |
| Carl Dockery | M | 61 | 8 years | |
| Abhinav Jain | M | 33 | 1 years | |
| Russell McMahen | M | - | 3 years | |
| Victoria Cordova | F | - | 1 years | |
| Margaret Cabano | F | - | 19 years | |
| Ryan J. Selhorn | M | 42 | - | |
| Suzane Kennedy | F | - | 6 years | |
| Greg Pyszczymuka | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gary V. Cantrell | M | 69 |
Vyrix Pharmaceuticals, Inc.
Vyrix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vyrix Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It maximizes the clinical and commercial potential of its late-stage sexual dysfunction products. The company is currently focused on advancing the development of Zertane™ for Premature Ejaculation (PE) in the US and around the world. Vyrix Pharmaceuticals was founded on November 18, 2013 and is headquartered in Greenwood Village, CO. | 8 years |
| David Green | M | 61 | 5 years | |
| Garrison Hasara | M | 54 | 10 years | |
| Richard Eisenstadt | M | 66 | - | |
| Michael E. Macaluso | M | 72 |
Vyrix Pharmaceuticals, Inc.
Vyrix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vyrix Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It maximizes the clinical and commercial potential of its late-stage sexual dysfunction products. The company is currently focused on advancing the development of Zertane™ for Premature Ejaculation (PE) in the US and around the world. Vyrix Pharmaceuticals was founded on November 18, 2013 and is headquartered in Greenwood Village, CO. | 7 years |
| Gregory Gould | M | 58 | 2 years | |
| Frank O'Donnell | M | 74 | - | |
| Samuel Duffey | M | 78 | 10 years | |
| Jonathan Heath McGrael | M | - | - | |
| Ketan B. Mehta | M | 62 | 3 years | |
| Steven Boyd | M | 43 | 2 years | |
| Mark D. McGregor | M | 82 |
Vyrix Pharmaceuticals, Inc.
Vyrix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vyrix Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It maximizes the clinical and commercial potential of its late-stage sexual dysfunction products. The company is currently focused on advancing the development of Zertane™ for Premature Ejaculation (PE) in the US and around the world. Vyrix Pharmaceuticals was founded on November 18, 2013 and is headquartered in Greenwood Village, CO. | - |
| Beth Hecht | F | 60 | - | |
| Christopher Brooke | M | - | 2 years | |
| Vaughan Lennox Clift | M | 62 |
Vyrix Pharmaceuticals, Inc.
Vyrix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vyrix Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It maximizes the clinical and commercial potential of its late-stage sexual dysfunction products. The company is currently focused on advancing the development of Zertane™ for Premature Ejaculation (PE) in the US and around the world. Vyrix Pharmaceuticals was founded on November 18, 2013 and is headquartered in Greenwood Village, CO. | - |
| James McNulty | M | 73 | 11 years | |
| David Schubert | M | 57 | - | |
| Nicholas J. Leb | M | - |
Vyrix Pharmaceuticals, Inc.
Vyrix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vyrix Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It maximizes the clinical and commercial potential of its late-stage sexual dysfunction products. The company is currently focused on advancing the development of Zertane™ for Premature Ejaculation (PE) in the US and around the world. Vyrix Pharmaceuticals was founded on November 18, 2013 and is headquartered in Greenwood Village, CO. | - |
| Alan M. Pearce | M | 75 | 6 years | |
| John P. Dubinsky | M | 80 | 3 years | |
| James A. Wachholz | M | 70 | 2 years | |
| Gerald McLaughlin | M | 56 | - | |
| Carl Ray Holman | M | 82 | - | |
| R. Scott Jones | M | 66 | 2 years | |
| Angelos Stergiou | M | 48 | 4 years | |
| Steven R. Arikian | M | 65 | 6 years | |
| Matthew Phillips | M | 56 | - | |
| David Redmond | M | 72 | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 40 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jarrett Disbrow
- Personal Network
